Speaking at the India-UK JETCO Business Plenary on Monday, Goyal highlighted the complementary nature of the two economies and stressed the...

Given the current global and domestic situation, the chances are that the volatility quotient in the market will remain high. So, the best ...

Indian pharma and chemical companies at CPHI Milan say the China+1 opportunity is real, but a “missing middle” in the MSME ecosystem, marke...

The Nifty snapped its eight-week losing streak but remains below the crucial 200-week moving average at 22,627. The weekly market outlook p...

Hospital stocks rose up to 5% after the government capped trade margins on non-scheduled anti-cancer drugs at 30%, potentially reducing med...

The RBI raised the repo rate by 25 basis points to 5.50%, its first hike in nearly four years. Mutual fund managers favour short-duration, ...

Because each pharma company took a different road, they no longer rise and fall together. Where any one of them stands in 10 years depends ...

NSE shares have slipped below their IPO price after a brief listing-day rally, wiping out nearly Rs 41,000 crore from the exchange’s peak m...

Indian pharmaceutical leaders emphasize the need for investment in innovation to transition from generics to innovative products. They high...

For the next few weeks, the markets will readjust as business updates, which have started to arrive, and the Q2 earnings numbers roll in. C...

Indian equities continued their downward trend due to rising global bond yields and high crude oil prices. The Nifty 50 fell by 198.50 poin...

Bayer has announced a significant investment of $2.2 billion to establish a new pharmaceutical site in New Albany, Ohio. This project follo...

Eli Lilly has experienced significant growth, reaching a market capitalization over $1 trillion. The company aims to maintain its leadershi...

In an exciting development, Rasayan Labs has unveiled a groundbreaking AI-based platform to enhance computational chemistry and drug discov...

Indian equity benchmarks experienced a decline over two sessions due to profit booking and rising oil prices. The Nifty 50 index closed dow...

For decades, multinationals treated China primarily as either a vast growth market or a rising competitive threat. But as growth slows, com...

NSE slipped below their Rs 1,785 IPO price on Monday, taking its market capitalisation to Rs 4.36 lakh crore. Despite the decline, brokerag...